The TGA, an agency under Australia's Department of Health, announced that the changes were introduced "because of concerns with the prescribing of oral ivermectin for the claimed prevention or treatment of COVID-19."
The new restrictions mean that general practitioners may only prescribe the drug for TGA-approved conditions and not for other non-approved purposes—also referred to as "off-label" use. No penalties were specified in the TGA announcement in the event of a GP skirting the rules.
The Epoch Times has reached out to the TGA for further information.
Only certain specialists can continue to prescribe oral ivermectin for off-label use. They include infectious disease physicians, dermatologists, gastroenterologists, and hepatologists, the TGA announced.
Stromectol ivermectin 3mg is the only oral ivermectin product that is TGA-approved. The indications approved are river blindness, threadworm of the intestines, and scabies.
Ivermectin is not TGA-approved for use to treat COVID-19 in Australia. The TGA said that its use for COVID-19 in the general public is "currently strongly discouraged" by three entities—the National COVID Clinical Evidence Taskforce (pdf), the World Health Organization, and the U.S. Food and Drug Administration.